InnoThyroGen Horizon Europe Project

InnoThyroGen Horizon Europe Project is a pioneering initiative dedicated to advancing research services and innovation in the critical field of thyroid health. Based in Split, Split-Dalmatia County, this dynamic project is coordinated by the University of Split School of Medicine and is committed to exploring cutting-edge solutions for diagnosing and treating thyroid disorders, impacting millions worldwide. The project addresses significant challenges in thyroid care, including undiagnosed cases and difficulties in treatment efficacy, with a focus on leveraging genomic advancements to provide more personalized and precise care.

At InnoThyroGen Horizon Europe Project, we are revolutionizing thyroid disease management through the integration of next-generation sequencing, polygenic risk scores, and electronic health records. Our research aims to deliver more accurate predictions and personalized medical care, ultimately reducing healthcare costs and improving patient quality of life. This commitment to innovation is driven by a team of dedicated professionals, and we strive to be at the forefront of genomic research. The project location is Split, Split-Dalmatia County 21000, HR.

InnoThyroGen Horizon Europe Project is poised to transform the landscape of thyroid care by introducing personalized medicine into clinical practice. Through the development of specialized gene panels and the application of artificial intelligence, we are paving the way for a future where thyroid disorders are diagnosed earlier, treated more effectively, and managed with greater precision. The expertise and collaborative nature of InnoThyroGen ensure that it remains a leader in the advancement of thyroid health. We invite you to create a customized and exclusive company showcase and product listing on our platform to further highlight your vital contribution.